ALPHA-SYNUCLEIN KINASE

The invention provides agents and methods for treatment of diseases associat ed with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.

Saved in:
Bibliographic Details
Main Authors CHEREAU, DAVID, BANDUCCI, KELLY, FRIGON, NORMAND, L., JR, GRISWOLD-PRENNER, IRENE, GOLDSTEIN, JASON, BASI, GURIQBAL, S, ANDERSON, JOHN, P, CHILCOTE, TAMIE, J
Format Patent
LanguageEnglish
French
Published 09.08.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention provides agents and methods for treatment of diseases associat ed with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.
Bibliography:Application Number: CA20072641219